This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
LendingTree Q2 Earnings Surpass Estimates, EBITDA Improves Y/Y
by Zacks Equity Research
TREE's Q2 adjusted net income per share of $1.13 beat estimates as revenues and EBITDA increase sharply despite higher costs.
Here's What Key Metrics Tell Us About Tree.com (TREE) Q2 Earnings
by Zacks Equity Research
The headline numbers for Tree.com (TREE) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tree.com (TREE) Beats Q2 Earnings Estimates
by Zacks Equity Research
Tree.com (TREE) delivered earnings and revenue surprises of +16.49% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PGY's Asset-Light Balance Sheet Model: Does it Offer a Safe Bet?
by Nikita Kataruka
Pagaya's asset-light model shields it from credit risk while powering 213% YTD gains and sharp earnings growth forecasts.
Why Tree.com (TREE) Could Beat Earnings Estimates Again
by Zacks Equity Research
Tree.com (TREE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
New Strong Buy Stocks for July 28th
by Zacks Equity Research
MEDP, CBFV, CALX, TREE and HAS have been added to the Zacks Rank #1 (Strong Buy) List on July 28, 2025.
Best Value Stocks to Buy for July 28th
by Zacks Equity Research
TREE, CCK and FCCO made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 28, 2025.
Tree.com (TREE) Surges 22.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Tree.com (TREE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
3 Mortgage & Related Services Stocks to Watch Amid Industry Challenges
by Riya Anand
While relatively high mortgage rates will hurt the Zacks Mortgage & Related Services industry, companies WD, AGM and TREE are poised to navigate challenges.
PGY vs. TREE: Which Disruptive Lending Platform Has More Upside Ahead?
by Swayta Shah
Can Pagaya's AI-driven lending model and rapid revenue growth outpace LendingTree's marketplace dominance? Let's find out.
PGY Expects Double-Digit Top-Line Growth in 2025: What's Driving It?
by Swayta Shah
Pagaya raises 2025 revenue outlook on Q1 strength, as diversification and tech tools fuel top-line momentum.
PGY Shares Soar 100.9% YTD: Time to Buy More or Lock in Profits?
by Swayta Shah
Pagaya stock surges 100.9% YTD as its AI-powered lending model, diversified growth and lean balance sheet draw bullish sentiment. Is the stock still a buy?
Zacks Investment Ideas feature highlights: Carvana, Beyond Meat, Sprouts Farmers Market, Urban Outfitters and LendingTree
by Zacks Equity Research
CVNA, SFM, and URBN earn Zacks' top rank as CPI surprise boosts sentiment; EPS estimates surge across retail names.
Top Stocks to Watch After May's Optimistic CPI Data
by Shaun Pruitt
Optimistically, May's much-anticipated inflation data came in better than expected amid ongoing concerns that President Trump's tariffs could cause a cost surge.
Zacks Industry Outlook Highlights Lending Tree and Rocket Companies
by Zacks Equity Research
Lending Tree and Rocket Companies are part of the Zacks Industry Outlook article.
2 Mortgage & Related Services Stocks to Watch Despite Industry Woes
by Riya Anand
While relatively high mortgage rates will hurt the Zacks Mortgage & Related Services industry, companies TREE and RKT are well-positioned to navigate challenges.
LendingTree Q1 Earnings Surpass Estimates, Revenues Up Y/Y
by Zacks Equity Research
TREE's first-quarter 2025 results benefit from a rise in revenues and adjusted EBITDA. However, an increase in total expenses acts as a spoilsport.
Tree.com (TREE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Tree.com (TREE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tree.com (TREE) Beats Q1 Earnings Estimates
by Zacks Equity Research
Tree.com (TREE) delivered earnings and revenue surprises of 33.78% and 1.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
TFS Financial (TFSL) Matches Q2 Earnings Estimates
by Zacks Equity Research
TFS Financial (TFSL) delivered earnings and revenue surprises of 0% and 4.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
LendingTree & NerdWallet: Which Digital Finance Stock is a Smart Bet?
by Riya Anand
TREE and NRDS are expanding their market share in the digital marketplace. Read on to know which is a smart bet for now.
Is Lending Tree Stock Worth Investing Ahead of Its Q1 Earnings?
by Riya Anand
TREE is set to report first-quarter 2025 results next week. Read on to know whether you should buy the stock now or wait.
LendingTree Rises 9.9% in a Year: Is the Stock Worth Buying Now?
by Riya Anand
TREE's revenue diversification efforts and expense management initiatives look encouraging. Read on to see whether the stock deserves a spot in your portfolio.
Why Is Tree.com (TREE) Down 3.4% Since Last Earnings Report?
by Zacks Equity Research
Tree.com (TREE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree
by Zacks Equity Research
HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.